EverFlex Post Approval Study



Status:Completed
Conditions:Peripheral Vascular Disease
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:2/14/2019
Start Date:January 14, 2013
End Date:February 4, 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the EverfLex NitInol STent System Post Approval Study

This post-approval study is designed to confirm the long-term safety and effectiveness of the
EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial
femoral artery (SFA) and proximal popliteal arteries.


Inclusion Criteria:

- Is willing to comply with all follow-up evaluations at the specified times.

- Is at least 18 years old.

- Provides written informed consent prior to enrollment in the study.

Exclusion Criteria:

- Has any co-morbid condition that precludes endovascular treatment.
We found this trial at
1
site
Wake Heart Research
Raleigh, North Carolina 27610
Principal Investigator: Ravish Sachar, MD
?
mi
from
Raleigh, NC
Click here to add this to my saved trials